CAMP4 Therapeutics Corporation(CAMP)

Biotechnology · Cambridge, MA

$3.88-0.13 (-3.24%)

Delayed quote: Oct 6, 2026, 3:45 PM EDT

CAMP4 Therapeutics (CAMP) PE Ratio: History & Chart | TGMCharts

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T19:46:20.635Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:46:20.635Z.

Quote observation: 2026-10-06T19:45:11.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 3.8801
Unrounded diluted TTM EPS · period ending 2026-06-30: -2.23

FMP input reference: 5c882cca81b2c0fe2c09916b57b0a50c93804d18514abf2397940823ad07c5bd

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

CAMP PE Ratio Metrics

PE RATIO

N/A

CAMP Competitors' PE Ratio

CAMP

CAMP4 Therapeutics Corporation

Current

Market Cap

$243.49M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SLGL

Sol-Gel Technologies Ltd.

vs CAMP

Market Cap

$242.09M

PE Ratio

N/A

TTM Avg

50.66

3Y Avg

50.25

5Y Avg

404.96

LFCR

Lifecore Biomedical, Inc.

vs CAMP

Market Cap

$241.95M

PE Ratio

N/A

TTM Avg

80.39

3Y Avg

80.39

5Y Avg

80.39

GALT

Galectin Therapeutics Inc.

vs CAMP

Market Cap

$245.65M

PE Ratio

N/A

TTM Avg

2.96

3Y Avg

2.96

5Y Avg

2.96

QTTB

Q32 Bio Inc.

vs CAMP

Market Cap

$241.27M

PE Ratio

2.91

TTM Avg

4.27

3Y Avg

4.27

5Y Avg

3.78

IPSC

Century Therapeutics, Inc.

vs CAMP

Market Cap

$239.92M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HITI

High Tide Inc.

vs CAMP

Market Cap

$238.57M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QSI

Quantum-Si incorporated

vs CAMP

Market Cap

$238.38M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AKBA

Akebia Therapeutics, Inc.

vs CAMP

Market Cap

$237.81M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

UPB

Upstream Bio, Inc.

vs CAMP

Market Cap

$250.63M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
CAMP4 Therapeutics Corporation (CAMP)	$243.49M	N/A	N/A	N/A	N/A
Sol-Gel Technologies Ltd. (SLGL)vs ›	$242.09M	N/A	50.66	50.25	404.96
Lifecore Biomedical, Inc. (LFCR)vs ›	$241.95M	N/A	80.39	80.39	80.39
Galectin Therapeutics Inc. (GALT)vs ›	$245.65M	N/A	2.96	2.96	2.96
Q32 Bio Inc. (QTTB)vs ›	$241.27M	2.91	4.27	4.27	3.78
Century Therapeutics, Inc. (IPSC)vs ›	$239.92M	N/A	N/A	N/A	N/A
High Tide Inc. (HITI)vs ›	$238.57M	N/A	N/A	N/A	N/A
Quantum-Si incorporated (QSI)vs ›	$238.38M	N/A	N/A	N/A	N/A
Akebia Therapeutics, Inc. (AKBA)vs ›	$237.81M	N/A	N/A	N/A	N/A
Upstream Bio, Inc. (UPB)vs ›	$250.63M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$3.88

Forward EPS (Est.)

$-1.14

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

CAMP PE Ratio Metrics

CAMP Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics